FDA 483 - Pharmalogic Puerto Rico Inc - July 22, 2016

An FDA inspection of Lantheus MI Radipharmaceuticals Inc. in San Juan, PR, revealed a significant issue regarding the conditional release of PET drug products. The firm approved batches despite analytical equipment malfunctions without documenting efforts to prevent recurrence. This indicates a lapse in quality control and documentation practices.